Skip to main content
Canadian Family Physician logoLink to Canadian Family Physician
editorial
. 1993 Jun;39:1298-300, 1302-4.

Pharmaceutical advertising. Information or influence?

T Dixon
PMCID: PMC2379606  PMID: 8324397

Full text

PDF
1298

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Garfunkel J. M., Ulshen M. H., Hamrick H. J., Lawson E. E. Problems identified by secondary review of accepted manuscripts. JAMA. 1990 Mar 9;263(10):1369–1371. [PubMed] [Google Scholar]
  2. Garfunkel J. M., Ulshen M. H., Hamrick H. J., Lawson E. E. Problems identified by secondary review of accepted manuscripts. JAMA. 1990 Mar 9;263(10):1369–1371. [PubMed] [Google Scholar]
  3. Goldstein J. H. Of mugs and marketing. JAMA. 1991 May 8;265(18):2391–2392. [PubMed] [Google Scholar]
  4. Goldstein J. H. Of mugs and marketing. JAMA. 1991 May 8;265(18):2391–2392. [PubMed] [Google Scholar]
  5. Ingelfinger F. J. Annual discourse--swinging copy and sober science. N Engl J Med. 1969 Sep 4;281(10):526–532. doi: 10.1056/NEJM196909042811005. [DOI] [PubMed] [Google Scholar]
  6. Kessler D. A. Addressing the problem of misleading advertising. Ann Intern Med. 1992 Jun 1;116(11):950–951. doi: 10.7326/0003-4819-116-11-950. [DOI] [PubMed] [Google Scholar]
  7. Kessler D. A. Addressing the problem of misleading advertising. Ann Intern Med. 1992 Jun 1;116(11):950–951. doi: 10.7326/0003-4819-116-11-950. [DOI] [PubMed] [Google Scholar]
  8. Kessler D. A. Addressing the problem of misleading advertising. Ann Intern Med. 1992 Jun 1;116(11):950–951. doi: 10.7326/0003-4819-116-11-950. [DOI] [PubMed] [Google Scholar]
  9. Miller L. G., Blum A. Physician awareness of prescription drug costs: a missing element of drug advertising and promotion. J Fam Pract. 1993 Jan;36(1):33–36. [PubMed] [Google Scholar]
  10. Miller L. G., Blum A. Physician awareness of prescription drug costs: a missing element of drug advertising and promotion. J Fam Pract. 1993 Jan;36(1):33–36. [PubMed] [Google Scholar]
  11. Moser R. H. Advertising and our journal. Ann Intern Med. 1977 Jul;87(1):114–115. doi: 10.7326/0003-4819-87-1-114. [DOI] [PubMed] [Google Scholar]
  12. Relman A. S. Who reviews the ads? N Engl J Med. 1979 Nov 1;301(18):999–999. doi: 10.1056/NEJM197911013011811. [DOI] [PubMed] [Google Scholar]
  13. Rennie D. Editors and advertisements. What responsibility do editors have for the advertisements in their journals? JAMA. 1991 May 8;265(18):2394–2396. doi: 10.1001/jama.265.18.2394. [DOI] [PubMed] [Google Scholar]
  14. Smith M. C. Drug product advertising and prescribing: a review of the evidence. Am J Hosp Pharm. 1977 Nov;34(11):1208–1224. [PubMed] [Google Scholar]
  15. Wilkes M. S., Doblin B. H., Shapiro M. F. Pharmaceutical advertisements in leading medical journals: experts' assessments. Ann Intern Med. 1992 Jun 1;116(11):912–919. doi: 10.7326/0003-4819-116-11-912. [DOI] [PubMed] [Google Scholar]

Articles from Canadian Family Physician are provided here courtesy of College of Family Physicians of Canada

RESOURCES